Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: patents

June 8, 2023 Drug delivery / Pharma applications

Leading innovators in cyclodextrin drug conjugates

Cyclodextrin drug conjugates is a key innovation area in the pharmaceutical industry GlobalData’s analysis uncovers the companies at the forefront of

Continue reading

February 9, 2023 Drug delivery / Pharma applications

An overview of recent patents and future perspective based on cyclodextrin complexation

This article covers information about cyclodextrin and its various derivatives, its different manufacturing process, physicochemical properties, advantages, and recent advancements.

Continue reading

January 31, 2022 Drug delivery / Pharma applications

When Cyclodextrins Met Data Science: Unveiling Their Pharmaceutical Applications through Network Science and Text-Mining

This review of Rincón-López et al. (2021) was published in the special issue Pharmaceutical and Biomedical Applications of Cyclodextrins and

Continue reading

August 4, 2021 Drug delivery / Pharma applications

Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review

The development of remdesivir has been a breakthrough for COVID-19 treatment. It has been approved in about 50 countries since

Continue reading

January 4, 2021 E-ducation

Statistics of cyclodextrin-related publications and patents

The CD-related literature was evaluated based on Scopus search. The number of publications continued to increase reaching 2445 paper in

Continue reading

Recent Posts

  • Cyclodextrin-Branched Polymer Releasing Nitric Oxide with Fluorescent Self-Reporting and Its Combination with Doxorubicin
  • Innovative Titanium Coatings for Enhanced Dental Implants
  • Bio-inks for skin regeneration: phase-adaptive design, multifunctional platforms, and 4D bioprinting frontiers
  • FermenGIN: γ-Cyclodextrin Takes the Bitterness Out of Bioconverted Red Ginseng
  • New book on beta-cyclodextrin and its derivatives

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (359)
  • CD derivatives (442)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (827)
  • E-ducation (64)
  • Environmental (144)
  • Events (242)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (427)
  • Other industrial use (114)
  • Pharma applications (1,234)
  • Supramolecular systems (45)
  • Uncategorized (173)

Top Posts

  • Cyclodextrin-Branched Polymer Releasing Nitric Oxide with Fluorescent Self-Reporting and Its Combination with Doxorubicin
  • Innovative Titanium Coatings for Enhanced Dental Implants
  • Adsorption of PFAS to Cationic β-Cyclodextrin Polymers
  • Synthesis and potential applications of cyclodextrin-based metal–organic frameworks: a review
  • Comparative Study of Nanosuspensions for Acetogenins Delivery
  • A cyclodextrin polymer that could change the future of batteries
  • FermenGIN: γ-Cyclodextrin Takes the Bitterness Out of Bioconverted Red Ginseng
  • Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-07 for the Acute Treatment of Migraine
  • Preparation of photocrosslinked spherical hydrogels bearing β-cyclodextrin and application in immobilizing microbes to decompose organic pollutants
  • Old but Gold (literally)!

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...